Sign in Register

Arzerra (ofatumumab)

Advertisement

Last reviewed · Source: First Databank (FDB) drug data

Overview

USES: Ofatumumab is used to treat a certain type of cancer (chronic lymphocytic leukemia - CLL). Ofatumumab belongs to a class of drugs known as monoclonal antibodies. This medication works by stopping the growth of cancer cells.

Generic name: ofatumumab
Pronunciation: (oh-fuh-TOO-muh-mab)

Reference product & biosimilars

No reference, biosimilar or interchangeable associated with this drug.

Today’s intelligence on Arzerra

Intelligence content is not available yet.

Indications

The following indications are listed for Arzerra:

  • Chronic Lymphocytic Leukemia
  • Progressive Chronic Lymphocytic Leukemia
  • Relapsed Chronic Lymphocytic Leukemia

Also known as: B-Cell Chronic Lymphocytic Leukemia, B-Cell Cll, Chronic B-Cell Leukemia, Chronic B-Lymphocytic Leukemia, Chronic Lymphatic Leukemia, Chronic Lymphocytic Leukemia In Relapse, Chronic Lymphocytic Leukemia Of B-Cell Type, Chronic Lymphocytic Leukemia, B-Cell, Progressive Cll, Refractory Chronic Lymphocytic Leukemia, Refractory Cll.

Dosing

No dosing information is available for this tab.

Drug interactions

There is no enhanced messaging for this drug.

Contraindications

There is no enhanced messaging for this drug.

Adverse reactions

There is no enhanced messaging for this drug.

Precautions

No enhanced messaging available.

ICD codes

No ICD codes are available for this drug.

Formulary status

Search health-plan coverage for this drug by ZIP code.

Enter a 5-digit ZIP code. Searching does not change your profile.

Enter a ZIP code to view available health plans.

Last reviewed · Source: First Databank (FDB) drug data